Experiments for taxon Phagnalon rupestre (ASTERACEAE)

Experiments (56 results)

Filters
Worktypes (21)
18
17
13
9
6
6
6
6
6
6
5
3
2
1
1
1
1
1
1
1
1
No match
Pharmacology (11)
8
5
5
2
2
1
1
1
1
1
29
No match
Compounds (28)
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
30
No match
Organisms (13)
17
11
8
4
4
2
2
2
2
1
1
1
1
No match
56 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
782439
VOUCHER SPECIMEN REPORTED FOR
Phagnalon rupestre (ASTERACEAE)
699306
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIMALARIAL ACTIVITY
Phagnalon rupestre (ASTERACEAE)
689477
PHARMACOLOGY OF EXTRACT - IN VITRO
MUTAGENIC ACTIVITY
Phagnalon rupestre (ASTERACEAE)
915489
MEDICINAL FOLKLORE REPORTED FOR
ANTIBURN EFFECT
Phagnalon rupestre (ASTERACEAE)
295905
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Phagnalon rupestre (ASTERACEAE)
CYNAROSIDE
295900
VOUCHER SPECIMEN REPORTED FOR
Phagnalon rupestre (ASTERACEAE)
782441
PHARMACOLOGY OF EXTRACT - IN VIVO
DELAYED TYPE CUTANEOUS HYPERSENSITIVITY INHIBITION
Phagnalon rupestre (ASTERACEAE)
782451
PHARMACOLOGY OF COMPOUND - IN VIVO
DELAYED TYPE CUTANEOUS HYPERSENSITIVITY INHIBITION
Phagnalon rupestre (ASTERACEAE)
CHLOROGENIC ACID C,ISO: METHYL ESTER
1120661
PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Phagnalon rupestre (ASTERACEAE)
726417
PHARMACOLOGY OF EXTRACT - IN VITRO
LARVICIDAL ACTIVITY
Phagnalon rupestre (ASTERACEAE)
689483
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIYEAST ACTIVITY
Phagnalon rupestre (ASTERACEAE)
589252
MEDICINAL FOLKLORE REPORTED FOR
ANTIBURN EFFECT
Phagnalon rupestre (ASTERACEAE)
782446
PHARMACOLOGY OF COMPOUND - IN VIVO
DELAYED TYPE CUTANEOUS HYPERSENSITIVITY INHIBITION
Phagnalon rupestre (ASTERACEAE)
HYDROQUINONE,2-(3'-3'-DIMETHYL-ALLYL): 1-O-BETA-D-GLUCOSIDECHLOROGENIC ACID A,ISO: METHYL ESTERHYDROQUINONE,2-(3'-3'-DIMETHYL-ALLYL): 1-O-(4''-O-CAFFEOYL)-BETA-D-GLUCOPYRANOSYL:HYDROQUINONECHLOROGENIC ACID C,ISO:CYNAROSIDE
689478
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Phagnalon rupestre (ASTERACEAE)
281993
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Phagnalon rupestre (ASTERACEAE)
BENZENE,1-O-BETA-GLUCOPYRANOSYL-1-4-DIHYDROXY-2-(3'-3'-DIMETHYL-ALLYL):
295901
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Phagnalon rupestre (ASTERACEAE)
FURAN,7-7'-BIS-(4-HYDROXY-3-5-DIMETHOXY-PHENYL)-8-8'-DIHYDROXY-METHYL-TETRAHYDRO: 4-O-BETA-GLUCOPYRANOSIDE
295904
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Phagnalon rupestre (ASTERACEAE)
COSMOSIIN
689476
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Phagnalon rupestre (ASTERACEAE)
782447
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Phagnalon rupestre (ASTERACEAE)
HYDROQUINONE,2-(3'-3'-DIMETHYL-ALLYL): 1-O-(4''-O-CAFFEOYL)-BETA-D-GLUCOPYRANOSYL:
526271
IDENTIFICATION IN BY PAPER CHROMATOGRAPHY
Phagnalon rupestre (ASTERACEAE)
LUTEOLINCOSMOSIINAPIGENIN
1120660
PHYTOCHEMICAL SCREENING FORVOUCHER SPECIMEN REPORTED FOR
Phagnalon rupestre (ASTERACEAE)
O
589251
VOUCHER SPECIMEN REPORTED FOR
Phagnalon rupestre (ASTERACEAE)
699304
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Phagnalon rupestre (ASTERACEAE)
782440
PHARMACOLOGY OF EXTRACT - IN VIVO
DELAYED TYPE CUTANEOUS HYPERSENSITIVITY INHIBITION
Phagnalon rupestre (ASTERACEAE)
689473
PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FOR
ANTICRUSTACEAN ACTIVITY
Phagnalon rupestre (ASTERACEAE)
782450
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Phagnalon rupestre (ASTERACEAE)
CHLOROGENIC ACID C,ISO: METHYL ESTER
281994
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Phagnalon rupestre (ASTERACEAE)
BENZENE,1-O-BETA-GLUCOPYRANOSYL-1-4-DIHYDROXY-2-(3'-HYDROXY-METHYL-3'-METHYL-ALLYL):
782448
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Phagnalon rupestre (ASTERACEAE)
HYDROQUINONE
782455
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Phagnalon rupestre (ASTERACEAE)
CYNAROSIDE
295906
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Phagnalon rupestre (ASTERACEAE)
LUTEOLIN-7-O-BETA-GLUCURONIDE
982039
IDENTIFICATION IN BY GC/MS
Phagnalon rupestre (ASTERACEAE)
THYMOLFARNESYL ACETONE,HEXAHYDRO:OCTADECANE,N:DODECANE,TRIMETHYL:TERPINEOL,BETA:
699303
PHARMACOLOGY OF EXTRACT - IN VITRO
PLANT ROOT GROWTH INHIBITION
Phagnalon rupestre (ASTERACEAE)
295903
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Phagnalon rupestre (ASTERACEAE)
TREMETONE,12-O-BETA-GLUCOPYRANOSYL-9-12-DIHYDROXY:
782454
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Phagnalon rupestre (ASTERACEAE)
CHLOROGENIC ACID C,ISO:
689475
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Phagnalon rupestre (ASTERACEAE)
782442
PHARMACOLOGY OF EXTRACT - IN VIVO
DELAYED TYPE CUTANEOUS HYPERSENSITIVITY INHIBITION
Phagnalon rupestre (ASTERACEAE)
782444
PHARMACOLOGY OF EXTRACT - IN VIVO
DELAYED TYPE CUTANEOUS HYPERSENSITIVITY INHIBITION
Phagnalon rupestre (ASTERACEAE)
689481
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Phagnalon rupestre (ASTERACEAE)
474886
ISOLATION AND IDENTIFICATION OF
Phagnalon rupestre (ASTERACEAE)
BENZOQUINONE,1-4: 2-DIMETHYL-ALLYL:
782453
PHARMACOLOGY OF COMPOUND - IN VIVO
DELAYED TYPE CUTANEOUS HYPERSENSITIVITY INHIBITION
Phagnalon rupestre (ASTERACEAE)
CHLOROGENIC ACID A,ISO:
782443
PHARMACOLOGY OF EXTRACT - IN VIVO
DELAYED TYPE CUTANEOUS HYPERSENSITIVITY INHIBITION
Phagnalon rupestre (ASTERACEAE)
689480
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Phagnalon rupestre (ASTERACEAE)
295907
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Phagnalon rupestre (ASTERACEAE)
PICEIN
281995
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Phagnalon rupestre (ASTERACEAE)
BENZENE,1-O-(4''-O-CAFFEOYL)-BETA-GLUCOPYRANOSYL-1-4-DIHYDROXY-2-(3'-3'-DIMETHYL-ALLYL):
699305
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Phagnalon rupestre (ASTERACEAE)
689474
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Phagnalon rupestre (ASTERACEAE)
689482
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Phagnalon rupestre (ASTERACEAE)
782445
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Phagnalon rupestre (ASTERACEAE)
HYDROQUINONE,2-(3'-3'-DIMETHYL-ALLYL): 1-O-BETA-D-GLUCOSIDE
782449
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Phagnalon rupestre (ASTERACEAE)
CHLOROGENIC ACID A,ISO: METHYL ESTER
281992
VOUCHER SPECIMEN REPORTED FOR
Phagnalon rupestre (ASTERACEAE)
726416
VOUCHER SPECIMEN REPORTED FOR
Phagnalon rupestre (ASTERACEAE)
331259
GC DATA REPORTEDIDENTIFICATION OFQUANTITATIVE DATA REPORTEDCHEMOTAXONOMY MARKER CODE
Phagnalon rupestre (ASTERACEAE)
TRITRIACONTANE,N:
295902
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Phagnalon rupestre (ASTERACEAE)
BENZENE,1-O-BETA-GLUCOPYRANOSYL-4-HYDROXY-2-(3'-HYDROXY-3'-METHYL-BUTYL):
915488
VOUCHER SPECIMEN REPORTED FOR
Phagnalon rupestre (ASTERACEAE)
689479
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Phagnalon rupestre (ASTERACEAE)
782452
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Phagnalon rupestre (ASTERACEAE)
CHLOROGENIC ACID A,ISO: